According to the government, these providers submitted false claims to MassHealth for urine drug tests and home health services.

The firm said that a strong start to the commercialization of its Liaison Plex platform also aided growth in its molecular diagnostics business.

The instrument is used for advanced immunohistochemistry, in situ hybridization, and fluorescence in situ hybridization applications.

The firm's Italian distributor A.D.A. is beginning a four-hospital study in collaboration with the Italian Society for Clinical Microbiology to evaluate the system.

The firm is preparing for a trial to show the efficacy of its CyPath Lung test and support a submission to the US Food and Drug Administration for marketing clearance.

St. Louis-based C2N said it will use the funds to scale its clinical laboratory services and Alzheimer's testing capabilities.

Mainz Biomed has the exclusive rights to develop a test for early pancreatic cancer detection using Liquid Biosciences' biomarkers.

The abolishment of the agency is aimed at reducing bureaucracy and the duplication of services provided by the UK Department of Health and Social Care.

The executives pleaded guilty to concealing a device malfunction that produced inaccurately low lead test results.

A study published in November in the American Journal of Clinical Pathology that Emerson co-authored validated the analyzer against the Sysmex XN Automated Hematology System and found that CytoChip's ...

The test will be reimbursed at the price of $1,495 for Medicare patients during the initial nine-month ADLT period starting on April 1.

NEW YORK – Former Magellan Diagnostics CEO Amy Winslow pleaded guilty to violating the federal Food, Drug and Cosmetic Act in a case related to the malfunctioning of Magellan's lead-testing devices.